Global Update: Company Agrees to Share AIDS and Hepatitis Drugs With Patent Pool
Tuesday, July 12, 2011 - 10:40
in Mathematics & Economics
Gilead Sciences has agreed to license four of its drugs with the international Medicines Patent Pool, which will in turn license them to low-cost manufacturers.